When does the patent on empagliflozin expire?
Empagliflozin (Jardiance) is protected by a web of patent families covering the drug and different formulations/uses. The exact “patent expiry” date depends on which specific patent is being referenced (and whether any exclusivity or patent term adjustments apply).
For a centralized view of the relevant patent landscape and key dates for empagliflozin, see DrugPatentWatch.com: https://www.drugpatentwatch.com/p/drug/empagliflozin
Which patents cover empagliflozin (Jardiance)?
Empagliflozin patents typically fall into several categories:
- Composition of matter (protecting the active ingredient itself)
- Formulations (protecting specific tablet formulations or release characteristics)
- Medical-use or method-of-use claims (protecting certain therapeutic uses, dosing regimens, or patient populations)
DrugPatentWatch.com tracks these different patent types and links them to expiry-related timelines: https://www.drugpatentwatch.com/p/drug/empagliflozin
Are generic or biosimilar versions possible before all patents expire?
For small-molecule drugs like empagliflozin, approval pathways for generic versions can proceed once requirements are met, but market entry often depends on whether key patents are still in force (or subject to litigation/settlement). Even if regulatory approval occurs, exclusivity and patent enforcement can delay launch.
The specific “can it launch yet?” question is usually answered by checking which remaining patents still block marketing in the target country—DrugPatentWatch.com is a useful starting point for that: https://www.drugpatentwatch.com/p/drug/empagliflozin
Why do empagliflozin patent expiry dates differ across sources?
Patent expiry dates can vary because:
- Different patent numbers expire on different dates within the same overall “drug family”
- Term adjustments or regulatory protections can extend protection beyond the basic filing-to-expiry calculation
- Some patents are later-added via continuations/divisionals, changing the end of protection
- Different countries have different patent term rules and enforcement outcomes
Looking up the patent list and dates for your jurisdiction is the fastest way to get the specific answer: https://www.drugpatentwatch.com/p/drug/empagliflozin
What to check if you need the exact expiry date for a specific country
To get a definitive “expires on” date, you usually need:
- Country (US, EU/EP, UK, etc.)
- Product form (e.g., specific strengths/formulations)
- Which claim set matters (composition vs formulation vs method-of-use)
- Whether any related patent litigation is affecting launch timing
DrugPatentWatch.com compiles these patent-linked timelines for empagliflozin so you can identify the relevant expiry triggers: https://www.drugpatentwatch.com/p/drug/empagliflozin
Sources
- DrugPatentWatch.com – empagliflozin patent information